These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. A Case of Indeterminate Cutaneous Dendritic Cell Tumors in the Setting of Chronic Myelomonocytic Leukemia. Nyckowski T; Vance P; Marks E Am J Dermatopathol; 2022 Jun; 44(6):449-453. PubMed ID: 35385851 [TBL] [Abstract][Full Text] [Related]
12. Solitary cutaneous nodule of blastic plasmacytoid dendritic cell neoplasm progressing to overt leukemia cutis after chemotherapy: immunohistology and FISH analysis confirmed the diagnosis. Kaune KM; Baumgart M; Bertsch HP; Mitteldorf C; Müller-Hermelink HK; Haase D; Ghadimi BM; Schön MP; Neumann C Am J Dermatopathol; 2009 Oct; 31(7):695-701. PubMed ID: 19684511 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical analysis of CD123, CD56 and CD4 for the diagnosis of minimal bone marrow involvement by blastic plasmacytoid dendritic cell neoplasm. Hwang K; Park CJ; Jang S; Chi HS; Huh JR; Lee JH; Suh C; Lee KH Histopathology; 2013 Apr; 62(5):764-70. PubMed ID: 23470050 [TBL] [Abstract][Full Text] [Related]
14. [Differential diagnostic specific skin infiltrates in chronic myelomonocytic leukemia]. Federmann B; Metzler G; Bonzheim I; Fend F Pathologe; 2015 Sep; 36(5):494-7. PubMed ID: 26292933 [TBL] [Abstract][Full Text] [Related]
15. Atypical cutaneous histiocytic eruption in a patient with chronic myelomonocytic leukemia: A case report. Li JJ; Talam S; Star P; Getta B J Cutan Pathol; 2021 May; 48(5):680-688. PubMed ID: 33416192 [TBL] [Abstract][Full Text] [Related]
16. Lacking CD56 expression in a relapsing cutaneous blastic plasmacytoid dendritic cell neoplasm after allogeneic bone marrow transplantation: FISH analysis revealed loss of 11q. Mitteldorf C; Bertsch HP; Baumgart M; Haase D; Wulf G; Schön MP; Rosenwald A; Neumann C; Kaune KM J Eur Acad Dermatol Venereol; 2011 Oct; 25(10):1225-9. PubMed ID: 21923812 [TBL] [Abstract][Full Text] [Related]
17. Chronic myelomonocytic leukemia and blastic plasmacytoid dendritic cell neoplasm. A case report and systematic review. Espasa A; Sorigue M; Tapia G; Cabezon M; Vergara S; Raya M; Navarro JT; Junca J; Zamora L; Xicoy B Cytometry B Clin Cytom; 2021 May; 100(3):292-295. PubMed ID: 32830878 [No Abstract] [Full Text] [Related]
18. The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias. Rollins-Raval MA; Roth CG Histopathology; 2012 May; 60(6):933-42. PubMed ID: 22348485 [TBL] [Abstract][Full Text] [Related]
19. Blastic plasmacytoid dendritic cell neoplasm: a clinicopathologic review. Shi Y; Wang E Arch Pathol Lab Med; 2014 Apr; 138(4):564-9. PubMed ID: 24678689 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features and prognostic significance of CXCL12 in blastic plasmacytoid dendritic cell neoplasm. Hashikawa K; Niino D; Yasumoto S; Nakama T; Kiyasu J; Sato K; Kimura Y; Takeuchi M; Sugita Y; Hashimoto T; Ohshima K J Am Acad Dermatol; 2012 Feb; 66(2):278-91. PubMed ID: 21835496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]